Vivos Inc (RDGL)

[DPep]

The company should not have been proposing higher doses than what they have found out already, so the leakage should not be changing AND there is much less leakage than seed therapy. I believe they have been monitoring leakage for all the procedures - or they should have been for all unique types of use, just would make sense right?
This potential requests sounds more like a monitoring program for the human trials on the varying types of cancer masses.

Has there been anything written about activity levels post procedure that could cause say a burst? That probably falls into accident category but I can't imagine it being different than migrating seeds?

I did not like reading that last portion but feel they have prepared themselves as much as they can without knowing how the initial discussion will be going.
Thanks to the Doc for the upfront information on potential additional testing, much better than finding out as a surprise post meeting. Please keep these types of updates coming, they are very much appreciated!